Filing Flows

Filing Flows › Health Catalyst (HCAT) › Next earnings date

Health Catalyst (HCAT) earnings: beat the estimate

Health Catalyst (HCAT) reported on Nov 5, 2026 and beat the EPS estimate: −$0.03 against −$0.05 (+36.8%). Revenue was $56.3M for Q3 2026, -26% year over year. It beat the EPS estimate in 60% of the quarters on record.

Last result+36.8% vs estimate
Beat rate60%

The last report

Health Catalyst reported revenue of $56.3M for the third quarter 2026 (-26% Y/Y), net earnings $40.5M: Technology $40.7M, Accumulated Impairment Losses $15.6M. How it makes money → · Every quarter →

Health Catalyst: EPS against the estimate, last 5 reportsHealth Catalyst: EPS against the estimate, last 5 reportsEstimateReported$0.07$0.06Nov 25$0.10$0.08Mar 26$0.01$0.02May 26$0.03$0.04Aug 26−$0.05−$0.03Nov 26
Latest (Nov 26): Estimate −$0.05, Reported −$0.03.
HCAT: the stock's move on each reportHCAT: the stock's move on each reportAug 6, 2026-27.6%May 11, 2026-2.6%Mar 12, 2026-29.0%Nov 10, 2025-4.9%

Health Catalyst's latest quarter

Health Catalyst, Q3 2026: revenue $56.3M (-26% year over year), operating margin 89.1%, net earnings $40.5M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.

Questions

Did Health Catalyst beat earnings?

Health Catalyst (HCAT) reported on Nov 5, 2026 and beat the EPS estimate: −$0.03 against −$0.05 (+36.8%).

When does HCAT report earnings?

The next date is not set yet.

Does Health Catalyst usually beat earnings?

It beat the consensus EPS estimate in 60% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.